SUMINISTRO DE LOS MEDICAMENTOS EXCLUSIVOS JAKAVI (PRINCIPIO ACTIVO RUXOLITINIB), REVOLADE (PRINCIPIO ACTIVO ELTROMBOPAG) Y CONSENTYX (PRINCIPIO ACTIVO SECUKINUMAB) CON DESTINO A LOS SERVICIOS DE FARMACIA DEL SERVICIO RIOJANO DE SALUD

Contract type	Supplies
CPV	33600000
Awarded to	Novartis Farmaceútica SA

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.